Your browser doesn't support javascript.
loading
The mechanism of action of MF59 - an innately attractive adjuvant formulation.
O'Hagan, D T; Ott, G S; De Gregorio, E; Seubert, A.
Affiliation
  • O'Hagan DT; Novartis Vaccines & Diagnostics, Cambridge, MA 02139, United States. derek.ohagan@novartis.com
Vaccine ; 30(29): 4341-8, 2012 Jun 19.
Article in En | MEDLINE | ID: mdl-22682289

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Squalene / Adjuvants, Immunologic Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Squalene / Adjuvants, Immunologic Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Journal: Vaccine Year: 2012 Document type: Article Affiliation country: Estados Unidos Country of publication: Países Bajos